首页> 美国卫生研究院文献>Journal of Korean Medical Science >Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): Ability to Predict Cancer Progression and Decision-Making Regarding Adjuvant Therapy after Radical Prostatectomy
【2h】

Cancer of the Prostate Risk Assessment (CAPRA) Preoperative Score Versus Postoperative Score (CAPRA-S): Ability to Predict Cancer Progression and Decision-Making Regarding Adjuvant Therapy after Radical Prostatectomy

机译:前列腺癌风险评估(CAPRA)术前评分与术后评分(CAPRA-S):能够预测癌症进展和根治性前列腺切除术后辅助治疗的决策能力

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The University of California, San Francisco, announced in 2011 Cancer of the Prostate Risk Assessment Postsurgical (CAPRA-S) score which included pathologic data, but there were no results for comparing preoperative predictors with the CAPRA-S score. We evaluated the validation of the CAPRA-S score in our institution and compare the result with the preoperative progression predictor, CAPRA score. Data of 130 patients were reviewed who underwent radical prostatectomy for localized prostate cancer from 2008 to 2013. Performance of CAPRA-S score in predicting progression free probabilities was assessed through Kaplan Meier analysis and Cox proportional hazards regression test. Additionally, prediction probability was compared with preoperative CAPRA score by logistic regression analysis. Comparing CAPRA score, the CAPRA-S score showed improved prediction ability for 5 yr progression free survival (concordance index 0.80, P = 0.04). After risk group stratification, 3 group model of CAPRA-S was superior than 3 group model of CAPRA for 3-yr progression free survival and 5-yr progression free survival (concordance index 0.74 vs. 0.70, 0.77 vs. 0.71, P < 0.001). Finally the CAPRA-S score was the more ideal predictor concerned with adjuvant therapy than the CAPRA score through decision curve analysis. The CPARA-S score is a useful predictor for disease progression after radical prostatectomy.Graphical Abstract
机译:加利福尼亚大学旧金山分校在2011年宣布了前列腺癌手术后癌症风险评估(CAPRA-S)评分,其中包括病理数据,但尚无将术前预测指标与CAPRA-S评分进行比较的结果。我们评估了机构中CAPRA-S评分的有效性,并将结果与​​术前进展预测指标CAPRA评分进行了比较。回顾性分析了2008年至2013年针对局部前列腺癌行根治性前列腺切除术的130例患者的数据。通过Kaplan Meier分析和Cox比例风险回归测试评估了CAPRA-S评分预测无进展概率的表现。此外,通过逻辑回归分析将预测概率与术前CAPRA评分进行比较。比较CAPRA评分,CAPRA-S评分显示5年无进展生存期的预测能力得到改善(一致性指数0.80,P = 0.04)。风险组分层后,在3年无进展生存期和5年无进展生存期方面,CAPRA-S的3组模型优于CAPRA的3组模型(一致性指数0.74对0.70、0.77对0.71,P <0.001 )。最后,通过决策曲线分析,CAPRA-S评分是比CAPRA评分更理想的辅助治疗预测指标。 CPARA-S评分是前列腺癌根治术后疾病进展的有用预测指标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号